Anca Nenicu

No ORCID on file · 4 papers in corpus · active 2014-2021

Study types

  • article 4

Condition tags

  • mesh:D004715 4
  • endometriosis 3
article 2021
Human Reproduction ·doi:10.1093/humrep/deab139

STUDY QUESTION: Is there a difference in the growth and vascularization between murine endometriotic lesions originating from menstrual or non-menstrual endometrial fragments? SUMMARY ANSWER: Endometriotic lesions developing from menstrual …

article 2017
British journal of pharmacology ·doi:10.1111/bph.13874

BACKGROUND AND PURPOSE: Telmisartan suppresses the development of endometriotic lesions. However, the drug also up-regulates the expression of COX-2, which has been suggested to promote the progression of endometriosis. Accordingly, in the …

article 2016
The American journal of pathology ·doi:10.1016/j.ajpath.2016.04.004
article 2014
Human Reproduction ·doi:10.1093/humrep/deu035

STUDY QUESTION: Is telmisartan effective in the treatment of endometriosis? SUMMARY ANSWER: Combined blockade of angiotensin II type 1 receptor (AT1R) and activation of peroxisome proliferator-activated receptor (PPAR)-γ by telmisartan inhi…